Characterization of RWJ-351647, a novel nonpeptide vasopressin V2 receptor antagonist

Clinical and Experimental Pharmacology & Physiology
Joseph W GunnetKeith T Demarest

Abstract

1. Antagonists of the V(2) vasopressin (AVP) receptor are aquaretic agents, inhibiting water resorption without stimulating electrolyte excretion. In this set of experiments, a novel V(2) receptor antagonist, RWJ-351647, was characterized in vitro and in vivo. 2. RWJ-351647 displaced (3)H-AVP binding from cloned human V(2) and V(1A) receptors with Ki values of 1 nmol/L and 24 nmol/L. In assays using transfected HEK293 cells expressing either human or rat V(2) receptors, RWJ-351647 inhibited AVP-induced cAMP accumulation with Ki values of 3 nmol/L and 6 nmol/L, respectively. 3. RWJ-351647 was very selective in binding assays and showed only weak functional antagonist activity at either the cloned human V(1B) and oxytocin receptors or the human platelet V(1A) receptor. No agonist activity was seen with the compound at any receptor. 4. Pharmacokinetic studies in rats showed RWJ-351647 to be 41.9% bioavailable after a single oral administration. After repeated daily dosing over 5 days, the oral bioavailability remained at 43.9% with no change in the compound peak plasma levels or clearance rate. 5. In efficacy studies, RWJ-351647 increased urine output and decreased urine osmolality with oral doses as low as 0.1 mg/kg and 1.0 mg/kg...Continue Reading

References

Feb 1, 1985·Annals of Internal Medicine·R J AndersonR W Schrier
Jul 1, 1993·Pharmaceutical Research·B Davies, T Morris
Nov 5, 1999·Cardiovascular Drugs and Therapy·A J Reyes, S H Taylor
Mar 14, 2001·Seminars in Nephrology·R W SchrierM A Cadnapaphornchai
Jul 31, 2001·Cardiovascular Research·L L Wong, J G Verbalis
Jun 14, 2002·Cardiovascular Research·Steven R Goldsmith
Jul 10, 2003·American Heart Journal·Craig R LeeKirkwood F Adams
Oct 21, 2003·The Journal of Thoracic and Cardiovascular Surgery·Niv AdJames L Cox
May 6, 2004·Bioorganic & Medicinal Chemistry Letters·Jay M MatthewsBruce E Maryanoff

❮ Previous
Next ❯

Citations

Sep 4, 2008·Heart Failure Reviews·Lisa C Costello-BoerrigterJohn C Burnett
Feb 2, 2011·Nature Reviews. Endocrinology·Gary L Robertson
Jan 26, 2007·Nature Clinical Practice. Nephrology·Sheldon ChenDaniel Batlle
Nov 23, 2006·Accounts of Chemical Research·Bruce E Maryanoff

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.

Related Papers

The New England Journal of Medicine
Wolfgang J WeiseVirginia L Hood
The New England Journal of Medicine
Robert W SchrierSALT Investigators
Hepatology : Official Journal of the American Association for the Study of Liver Diseases
Nicholas Shackel, Geoffrey McCaughan
© 2022 Meta ULC. All rights reserved